质瘤微环境及其对抗瘤免疫力的影响
Landon J Hansen1, Christopher M Jackson1
1Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Neuro-oncology advances
|September 11, 2025
概括
质母细胞瘤是一种具有攻击性的脑瘤,对当前的治疗方法具有抗性. 了解瘤微环境是开发新免疫疗法的关键,这些免疫疗法可以克服治疗障碍并改善患者的生存率.
科学领域:
- 神经瘤学神经瘤学
- 癌症免疫学 癌症免疫学
- 瘤微环境 (TME) 是指瘤的微环境.
背景情况:
- 质瘤,特别是高度质母细胞瘤,是具有不良预后的具有挑战性的脑瘤.
- 目前的治疗方法包括手术,放射和化疗,为质母细胞瘤患者提供有限的生存益处.
- 癌症免疫疗法在其他癌症中取得了成功,但在质母细胞瘤中面临重大障碍.
研究的目的:
- 审查质瘤瘤微环境 (TME) 的具体特征,这些特征阻碍了有效的免疫治疗.
- 讨论新兴的治疗策略,旨在克服这些TME所造成的障碍.
- 引导开发合理向的结合疗法用于质瘤.
主要方法:
- 关于质瘤生物学和瘤免疫学的当前科学文献的综述.
- 对质瘤TME内的解剖学,分子和功能障碍的分析.
- 检查新的免疫疗法方法和组合策略.
主要成果:
- 质瘤TME在启动和维持抗瘤免疫反应方面存在多个障碍.
- 特定的TME成分会产生一种免疫抑制的环境,从而限制免疫疗法的有效性.
- 对TME障碍的洞察力正在使人们能够转向更有针对性的治疗开发.
结论:
- 克服免疫抑制性质瘤TME对于成功的质母细胞瘤免疫疗法至关重要.
- 根据TME研究,有针对性的组合疗法有望改善患者的治疗结果.
- 对TME调节的进一步研究对于推进质母细胞瘤治疗至关重要.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K


